SCHEMBL6327136

SCHEMBL6327136

CN(C(=O)c1ccc2c(NCc3cccc(C(=N)N)c3)ncnc2c1)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
MAPK1 P28482 4/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2C19 P33261 3/20 0.44
HSD17B10 Q99714 3/20 0.44
USP2 O75604 2/20 0.44
LMNA P02545 2/20 0.44
CYP2D6 P10635 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX12 P18054 1/20 0.44
AURKA O14965 6/20 0.43
AURKB Q96GD4 4/20 0.43
RPS6KB1 P23443 4/20 0.43
CLK4 Q9HAZ1 1/20 0.43
PDE5A O76074 1/20 0.42
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6324691 0.83 AURKA (0.48) MAPK1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL8304320 0.83 ALDH1A1 (0.49) MAPK1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL6329487 0.82 AURKA (0.43) MAPK1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL6322361 0.80 AURKA (0.49) POLBLMNAHPGDAURKAAURKB
SCHEMBL6325892 0.79 F10 (0.48) POLBLMNAHPGDAURKAAURKB
SCHEMBL8307208 0.79 F10 (0.48) POLBLMNAHPGDAURKAAURKB
SCHEMBL6322321 0.79 AURKA (0.42) AURKAAURKBRPS6KB1PDE5ACNR1
Hydrochloric Acid SCHEMBL6325502 0.78 F10 (0.47) POLBLMNAHPGDAURKAAURKB
SCHEMBL6329960 0.78 F10 (0.48) MAPK1AURKAAURKBRPS6KB1PDE5A
Hydrochloric Acid SCHEMBL6326766 0.77 F10 (0.48) MAPK1AURKAAURKBRPS6KB1PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions F12, F2, F11 POLB 3545/4885MAPK1 2554/4885ALDH1A1 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.